Article Information
History
- January 5, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Brian Arwah1,*,
- Samuel Mbugua2,
- Jane Ngure2,
- Mark Makau2,
- Peter Mwaura2,
- David Kamau2,
- Desire Aime Nshimirimana3,
- Edwine Barasa1,4,5 and
- Jesse Gitaka2
- 1Health Economics Research Unit, KEMRI – Wellcome Trust Research Programme
- 2Directorate of Grant and Development, Mount Kenya University, Thika Kenya
- 3Kenya Methodist University
- 4Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK
- 5Institute of Healthcare Management, Strathmore University Business School, Nairobi, Kenya
- ↵*Correspondence to: Brian Arwah; barwah{at}kemri-wellcome.org
Posted January 05, 2023.
Cost & Cost-Effectiveness of Implementing SD Biosensor Antigen Detecting SARs-CoV-2 Rapid Diagnostic Tests in Kenya
